newsfilter
← Earnings
Earnings Releases·

Enovis — Third Quarter 2026 Earnings Summary

Enovis reported third-quarter 2026 net sales of $559 million, representing a 2% increase on a reported basis and a 5% organic increase compared to the same period in 2025. The company achieved a net income of $3 million and adjusted EBITDA of $104 million, with Reconstructive sales growing 6% while Prevention & Recovery sales declined 2% on a reported basis. Enovis raised its full-year 2026 adjusted EBITDA guidance to a range of $428-438 million and adjusted EPS guidance to $3.58-3.79, while the Board of Directors approved a new $200 million share repurchase authorization.

Company
ENOVIS CORP
Sector
Healthcare
Industry
Medical Devices